| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 20.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT |
| ADMINISTRATION | INTRAVENOUS |
| PHYSICAL FORM | POWDER |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.0 MILLIGRAMS OF ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | CONTAINS 3000 MG MANNITO AND SUFFICIENT SODIUM HYDROXIDE TO YIELD A PH OF APPROX. 9.5; FOR RECONSTITUTION WATER FOR INJECTION WITHOUT BACTERIOSTATIC AGENT; FOR TREATMENT OF MALIGNANT HYPERTHERMIA |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |